2025-10-04 - Analysis Report
Okay, here's a comprehensive analysis of Honeywell International Inc. (HON), incorporating the provided data and recent news.

**Report: Honeywell International Inc. (HON) Analysis**

Honeywell International Inc. is a diversified technology and manufacturing company.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** HON
*   **Cumulative Return (HON):** 14.98%
*   **Cumulative Return (VOO):** 98.51%
*   **Return Disparity:**
    *   **Current:** -82.4
    *   **Max:** 14.0
    *   **Min:** -83.5
    *   **Relative Disparity:** 1.1

**Analysis:** HON has significantly underperformed the S&P 500 (VOO) over the period. The current disparity is near its historical minimum, indicating a large performance gap.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
| :----------- | :------ | :------ | :------ | :----- | :------- |
| 2015-2017  | 33.0%   | 67.3%   | 5.0%    | -0.0   | 93.3    |
| 2016-2018  | 15.0%   | 71.0%   | 0.0%    | 0.1    | 83.9    |
| 2017-2019  | 29.0%   | 71.1%   | 7.0%    | 1.0    | 112.4   |
| 2018-2020  | 6.0%    | 79.4%   | -18.0%  | 1.0    | 135.0   |
| 2019-2021  | 19.0%   | 79.4%   | -28.0%  | 1.2    | 132.4   |
| 2020-2022  | 9.0%    | 79.4%   | 10.0%   | 1.4    | 136.1   |
| 2021-2023  | -9.0%   | 77.9%   | -10.0%  | 1.2    | 133.1   |
| 2022-2024  | -2.0%   | 79.7%   | -22.0%  | 1.2    | 143.4   |
| 2023-2025  | -16.0%  | 79.7%   | -79.0%  | 2.0    | 132.7   |

*   **CAGR:** Fluctuating, with negative values in recent periods (2021-2025).
*   **MDD:** Consistently high, around 70-80%, indicating significant downside risk.
*   **Alpha:** Mostly negative in recent periods, suggesting underperformance relative to its risk-adjusted benchmark.
*   **Beta:** Generally around 1 or higher, indicating the stock's volatility is similar to or higher than the market.
*   **Cap(B):** Market Cap is steadily increasing year by year.

**2. Recent Stock Price Action**

*   **Current Price:** $209.05
*   **Previous Close:** $211.01
*   **Change:** -$0.93
*   **5-Day Moving Average:** 209.96
*   **20-Day Moving Average:** 210.69
*   **60-Day Moving Average:** 218.99

**Analysis:** The stock price is below all three moving averages, suggesting a short-term downtrend. The recent price decrease indicates negative momentum.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 38.72 (Approaching oversold territory)
*   **PPO:** 0.19
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (5 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **20-Day Relative Disparity Change:** -0.8 (Short-term decline)
*   **Expected Return:** -2512.9% (Significant underperformance expected vs. S&P 500 over the long term)

**Analysis:** The MRI suggests the stock is considered relatively safe despite recent price declines. RSI is approaching oversold territory. However, the negative expected return is a major concern, indicating potential underperformance in the long run. The Hybrid signal recommends to buy. The recent price drop (negative change) confirms negative momentum.

**4. Recent News & Significant Events**

*   **Dividend Increase:**  Honeywell will pay a larger dividend. (Positive)
*   **Analyst Target:** Deutsche Bank Adjusts Price Target on Honeywell International to $271 From $268, Maintains Buy Rating (Positive)
*   **Asbestos Liabilities:** Honeywell exits asbestos liabilities in a $1.68 billion deal. (Potentially Positive - removes uncertainty)
*   **Business Strength:** Honeywell benefits from business strength amid headwinds. (Positive)
*    **Jim Cramer on Resideo Technologies:** “It’s Kind of Played Out” (Neutral or negative)

**Analysis:**  The news is mixed. The dividend increase and analyst price target adjustments are positive. Exiting asbestos liabilities could reduce future risk. However, it's crucial to understand the financial impact of the $1.68 billion deal.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.96)
*   **Target Price (Avg/High/Low):** $253.11 / $290.00 / $210.00

**Analysis:**  Analysts generally have a positive outlook on Honeywell, with a "Buy" consensus and an average target price significantly higher than the current price.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
| :---------- | :--- | :---------- |
| 2025-07-24 | 2.46 | $10.35 B   |
| 2025-04-29 | 2.24 | $9.82 B    |
| 2024-10-24 | 2.17 | $9.73 B    |
| 2024-07-25 | 2.37 | $9.58 B    |
| 2025-07-24 | 2.37 | $9.58 B    |

**Analysis:** Revenue and EPS show an increasing trend in the first two quarters in 2025.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| :------------ | :--------- | :-------------- |
| 2025-06-30  | $10.35B    | 38.86%         |
| 2025-03-31  | $9.82B     | 38.54%         |
| 2024-12-31  | $10.09B    | 36.38%         |
| 2024-09-30  | $9.73B     | 38.54%         |
| 2024-06-30  | $9.58B     | 38.85%         |

**Capital and Profitability:**

| Quarter      | Equity     | ROE     |
| :------------ | :---------- | :------ |
| 2025-06-30  | $16.09B    | 9.75%   |
| 2025-03-31  | $17.46B    | 8.30%   |
| 2024-12-31  | $18.62B    | 6.90%   |
| 2024-09-30  | $17.41B    | 8.12%   |
| 2024-06-30  | $16.95B    | 9.11%   |

**Analysis:** Revenue is generally increasing. Profit margins are consistently high. Equity is showing a small downward trend, while ROE is fluctuating.

**7. Overall Assessment**

Honeywell (HON) presents a mixed picture. While analysts have a positive outlook and recent earnings and financial data show strength, the stock has significantly underperformed the S&P 500. The negative expected return is a serious concern, and the recent price action indicates a short-term downtrend. The MRI rating suggests that it might be a good investment, however recent indicators such as RSI, PPO and 20-Day Relative Disparity Change are still showing short term decline.

**Recommendation:**

A cautious approach is advised. Further investigation is needed to understand the reasons for the underperformance and the negative expected return.

